Gå ubegrenset med Magzter GOLD
Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare
Prøve GULL - Gratis
India cuts China bulk-drug reliance
Mint Hyderabad
|March 17, 2025
Bulk drugs accounted for 63% of the total pharmaceutical imports in the country during FY 2018-19
Indian companies have started manufacturing important bulk drugs or active pharmaceutical ingredients (APIs) under the government's production linked incentive (PLI) scheme.
The production of Penicillin G and Clavulanic Acid began in October last year. Other APIs already in production include Atorvastatin, Sulfadiazine, Telmisartan, Olmesartan, Para Amino Phenol (raw material for paracetamol) and Oxcarbazepine.
The development is set to make India less reliant on China for imports of raw material used by the pharmaceutical industry.
These bulk drugs are largely used as antibiotics and to manage non-communicable diseases such as cardiovascular diseases, chronic respiratory diseases, and diabetes.
Denne historien er fra March 17, 2025-utgaven av Mint Hyderabad.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Hyderabad
Mint Hyderabad
Cyberattack on vendor hits major US banks
Client data for JPMorgan Chase, Morgan Stanley Citi and other major banks may have been accessed in a hack of a tech vendor, The New York Times reported on Saturday, citing people familiar with the matter.
1 min
November 24, 2025
Mint Hyderabad
Walmart was once demonized but has transformed its image
Its staff-oriented strategy faced investor scepticism but has paid off
3 mins
November 24, 2025
Mint Hyderabad
India to curb antibiotic use in animals to control drug resistance
India has unveiled its next-generation national action plan on antimicrobial resistance (AMR 2.0) for 2025-2029, to curb misuse of antibiotics across humans and animals as drug-resistant infections emerge as a major national health threat.
2 mins
November 24, 2025
Mint Hyderabad
Amfi leads data drive as Sebi plans fee cap
The mutual fund industry is compiling an extensive dataset on portfolio churn and transaction costs to help the Securities and Exchange Board of India (Sebi) evaluate its proposal to sharply cap brokerage fees.
2 mins
November 24, 2025
Mint Hyderabad
Carlyle targeting $300 mn side fund
Carlyle Group Inc. is launching an India side fund to operate along the firm’s sixth pan-Asia investment vehicle, to tap opportunities in everything from tech to health care.
1 min
November 24, 2025
Mint Hyderabad
Embrace the quiet joy of doing nothing in retirement
In a world demanding constant action, finding stillness is the perfect, complementary antidote to an active retirement
3 mins
November 24, 2025
Mint Hyderabad
CAG plans shift to live audits to curb public funds misuse
The overhaul is designed to flag tendering lapses, execution delays and potential losses early
2 mins
November 24, 2025
Mint Hyderabad
'Stay invested in the stock market, everything is for the long haul'
Veteran value investor Ramesh Damani is ignoring doomsday warnings about a US tech stock correction and noises surrounding corporate earnings growth trajectory back home, staying loyal instead to his credo of long-term investments, using a bottom -up approach. He remains unconcerned about short term market corrections, advising investors to
5 mins
November 24, 2025
Mint Hyderabad
BirlaNu announces new Andhra plant
Building materials and home solutions company BirlaNu on Sunday announced plans to set up a greenfield fibre cement board plant in Nellore district of Andhra Pradesh.
1 min
November 24, 2025
Mint Hyderabad
OYO Assets gets 125 cr fresh funds
OYO parent PRISM-backed OYO Assets has raised ₹125 crore in a fresh funding round from a clutch of institutional and private investors led by InCred, people aware of the development said.
1 min
November 24, 2025
Listen
Translate
Change font size